Perspective Therapeutics
CATX
38 hedge funds and large institutions have $3.94M invested in Perspective Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0.23% less ownership
Funds ownership: 10.69% → 10.45% (-0.23%)
16% less capital inflows, than outflows
Capital inflows: $532K | Capital outflows: $631K
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$253K |
| 2 |
Bridgeway Capital Management
Houston,
Texas
|
+$183K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$33.6K |
| 4 |
Cerity Partners
New York
|
+$25.7K |
| 5 |
One Charles Private Wealth Services
Hingham,
Massachusetts
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM Investors
Solana Beach,
California
|
-$496K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50.8K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$50.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$22.9K |
| 5 |
Norris Financial Group
Greenville,
South Carolina
|
-$6.89K |
CATX Hedge Fund Activity: Q2 2020 in Review
38 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2020, worth a combined $3.94M — up 2.9% from $3.83M a quarter earlier.
Fund positioning in CATX was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 7 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $253K. The largest seller was EAM Investors, cutting an estimated $496K.
- 38 institutional investors held Perspective Therapeutics (CATX) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $3.94M of Perspective Therapeutics stock for Q2 2020, up 2.9% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q2 2020 and 4 closed out, a net change of 0 holders.
- The largest Perspective Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $253K added.
- The largest Perspective Therapeutics seller in Q2 2020 was EAM Investors, an estimated $496K sold.
Based on aggregated 13F filings for Q2 2020.